Skip to Content

FluLaval GlaxoSmithKline - Treatment for Prevention of Influenza

FluLaval is indicated for the active immunization of adults 18 years and older against influenza disease caused by influenza virus types A and B contained in the vaccine.

Posted: October 2006

Related Articles:

FluLaval (Influenza Virus Vaccine) FDA Approval History

View comments